Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA4284025
Max Phase: Preclinical
Molecular Formula: C48H61N7O12S
Molecular Weight: 960.12
Molecule Type: Small molecule
Associated Items:
ID: ALA4284025
Max Phase: Preclinical
Molecular Formula: C48H61N7O12S
Molecular Weight: 960.12
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: C[C@@H]1CC[C@H]2[C@@H](C)C(OCCNC3CCN(c4ccc(C(=O)NS(=O)(=O)c5ccc(NCC6CCOCC6)c([N+](=O)[O-])c5)c(Oc5cnc6[nH]ccc6c5)c4)CC3)O[C@@H]3O[C@@]4(C)CC[C@@H]1[C@]32OO4
Standard InChI: InChI=1S/C48H61N7O12S/c1-29-4-8-39-30(2)45(64-46-48(39)38(29)10-16-47(3,65-46)66-67-48)62-23-18-49-33-12-19-54(20-13-33)34-5-7-37(42(25-34)63-35-24-32-11-17-50-43(32)52-28-35)44(56)53-68(59,60)36-6-9-40(41(26-36)55(57)58)51-27-31-14-21-61-22-15-31/h5-7,9,11,17,24-26,28-31,33,38-39,45-46,49,51H,4,8,10,12-16,18-23,27H2,1-3H3,(H,50,52)(H,53,56)/t29-,30-,38+,39+,45?,46-,47-,48-/m1/s1
Standard InChI Key: IROMHTYFTLXWQY-XVQFLZNBSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 960.12 | Molecular Weight (Monoisotopic): 959.4099 | AlogP: 7.00 | #Rotatable Bonds: 15 |
Polar Surface Area: 226.97 | Molecular Species: ZWITTERION | HBA: 16 | HBD: 4 |
#RO5 Violations: 3 | HBA (Lipinski): 19 | HBD (Lipinski): 4 | #RO5 Violations (Lipinski): 3 |
CX Acidic pKa: 4.22 | CX Basic pKa: 9.73 | CX LogP: 5.63 | CX LogD: 5.63 |
Aromatic Rings: 4 | Heavy Atoms: 68 | QED Weighted: 0.04 | Np Likeness Score: 0.16 |
1. Liu X, Zhang Y, Huang W, Luo J, Li Y, Tan W, Zhang A.. (2018) Development of high potent and selective Bcl-2 inhibitors bearing the structural elements of natural product artemisinin., 159 [PMID:30278333] [10.1016/j.ejmech.2018.09.059] |
Source(1):